We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$27.2M
Cap. Flow
-$38M
Cap. Flow %
-20.28%
Top 10 Hldgs %
43.93%
Holding
89
New
25
Increased
12
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$5.07M
2
GILD icon
Gilead Sciences
GILD
+$4.16M
3
DXCM icon
DexCom
DXCM
+$2.66M
4
ETRM
EnteroMedics Inc.
ETRM
+$2.43M
5
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$2.39M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$4.51M
2
MRK icon
Merck
MRK
+$3.97M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.91M
4
STJ
St Jude Medical
STJ
+$3.64M
5
PBYI icon
Puma Biotechnology
PBYI
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 70.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRGO icon
76
CALL
Perrigo
PRGO
$1.7B
– –
-30,000
Closed -$4.37M
SPY icon
77
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
– –
-25,000
Closed -$4.89M
SUPN icon
78
CALL
Supernus Pharmaceuticals
SUPN
$2.76B
– –
-150,000
Closed -$1.64M
SVRA icon
79
Savara
SVRA
$1.15B
– –
-7,143
Closed -$315K
TEVA icon
80
Teva Pharmaceuticals
TEVA
$43.3B
– –
-50,000
Closed -$2.62M
VRTX icon
81
CALL
Vertex Pharmaceuticals
VRTX
$135B
– –
-35,000
Closed -$3.31M
LUMO
82
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-5,556
Closed -$1.33M
SRNE
83
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-130,000
Closed -$878K
ALXN
84
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-25,000
Closed -$3.91M
AKAO
85
DELISTED
Achaogen Inc
AKAO
– –
-75,000
Closed -$1.05M
TSRO
86
DELISTED
TESARO, Inc.
TSRO
– –
-50,000
Closed -$1.56M
IPXL
87
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-50,000
Closed -$1.5M
STJ
88
DELISTED
St Jude Medical
STJ
– –
-52,500
Closed -$3.64M
CELG
89
PUT
DELISTED
Celgene Corp
CELG
– –
-50,000
Closed -$4.29M
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2014 Portfolio in Review

As of Q3 2014, Iguana Healthcare Management held 89 positions worth $187M, down 13% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management withdrew a net $38M in Q3 2014, closing 25 positions and reducing 22 holdings. Its most notable exit was HCA Healthcare, an estimated $4.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier.

Against the trend, Iguana Healthcare Management opened a new position in Zimmer Biomet worth $5.03M.

  • Iguana Healthcare Management's largest Q3 2014 buy was Zimmer Biomet: 51,500 shares worth $5.03M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q3 2014, an estimated $4.16M increase.
  • Iguana Healthcare Management's biggest Q3 2014 reduction was Merck, cutting an estimated $3.97M.
  • Iguana Healthcare Management fully exited HCA Healthcare in Q3 2014, selling an estimated $4.51M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $187M portfolio in Q3 2014.
  • Iguana Healthcare Management opened 25 new positions and closed 25 in Q3 2014.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $187M.

Based on Iguana Healthcare Management's 13F filing for Q3 2014, filed 14 Nov 2014.